RHON-KLINIKUM AG Reports Stable First Half, Expands Regional Health Networks Amid Reform Pressures

RHON-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly up from EUR 833.5 million in the same period last year. EBITDA improved to EUR 57.0 million (H1 2025: EUR 46.7 million), and consolidated profit rose to EUR 22.5 million (H1 2025: EUR 14.7 million). The results were influenced by immediate transformation costs established to offset higher personnel and material costs from previous years. From January to June, the Group treated a total of 513,700 patients on an outpatient and inpatient basis, marking a 9% increase compared to 471,295 in the prior year.

The company continues to expand regional healthcare provision through strategic investments and partnerships. In Hesse, Universitatsklinikum Marburg and the pulmonary clinic Lungenfachklinik Immenhausen are pooling their expertise to improve care for lung patients. In Brandenburg, the newly opened child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site has established a robust regional network, supported by cooperation agreements with the City of Frankfurt (Oder) and the District of Oder-Spree to ensure coordinated help for affected children and adolescents.

Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently.”

However, the company faces headwinds from recent legislative changes. Dr. Stefan Stranz, also a Board member, criticized the Statutory Health Insurance Contribution Rate Stabilization Act, stating that it imposes further burdens on hospitals, increasing documentation requirements, budget cuts, and financial risks.

For the 2026 financial year, RHON-KLINIKUM expects revenues of EUR 1.7 billion (plus or minus 5%) and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates moderate improvements in non-financial performance indicators, including number of cases and cost weights. The forecast is subject to significant uncertainties due to ongoing regulatory changes, such as the Hospital Reform Adjustment Act (KHAG) and the GKV Contribution Rate Stabilisation Act (GKV-BStabG), which aim to enhance quality and efficiency but may increase financial pressure on hospitals in the short term.

The broader economic environment, including global crises, rising prices, and supply bottlenecks, adds to the volatility. The company notes that it is not yet possible to reliably forecast the full impact of regulatory interference and potential further adjustments. Despite these challenges, RHON-KLINIKUM remains committed to investing in state-of-the-art medical technology and expanding its regional care networks to ensure comprehensive, high-quality care, particularly in rural areas.